ODI Pharma AB (6OD) Income Statement

0 Followers

ODI Pharma AB Income Statement

Last quarter (Q2 2023), ODI Pharma AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, ODI Pharma AB's net income was $-1.74M. See ODI Pharma AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ -103.64K	$ 0.00	$ ―	$ ―
Operating Expenses	$ ―	$ ―	$ ―	$ ―
Depreciation and Amortization	$ 5.59K	$ 6.97K	$ 12.26K	$ 2.10K
EBITDA	$ -7.20M	$ -3.95M	$ -4.92M	$ -3.34M
Operating Income	$ -7.21M	$ -3.96M	$ -4.93M	$ -3.34M
Other Income/Expenses	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ ―	$ ―	$ ―
Net Income	$ -7.24M	$ -3.98M	$ -4.96M	$ -3.63M
Per Share Metrics
Basic EPS	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―
Weighted Average Shares Outstanding	―	―	―	―
Weighted Average Shares Outstanding (Diluted)	―	―	―	―

ODI Pharma AB (6OD) Income Statement

ODI Pharma AB Income Statement

ODI Pharma AB Earnings and Revenue History